Werner Creutzfeldt

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

J. Holst, M. Heimesaat, M. Nauck, 1993, The Journal of clinical investigation.

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

J. Holst, M. Nauck, W. Creutzfeldt, 1993, Diabetologia.

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).

J. Holst, M. Nauck, C. Qualmann, 1995, Scandinavian journal of gastroenterology.

Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis.

R. Lüdtke, W. Creutzfeldt, U. Fölsch, 1997, The New England journal of medicine.

Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).

W. Creutzfeldt, C. Creutzfeldt, R. Arnold, 1975, Human pathology.